Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Krishnan A, Sims OT, Surapaneni PK, Woreta TA, Alqahtani SA (2023) Risk of adverse cardiovascular outcomes among persons living with HIV and nonalcoholic fatty liver disease: a multicenter matched cohort study
Research explores its role in supporting neuronal function and resilience, while also examining metabolic regulation and adipocyte-targeting effects in experimental models of obesity and energy balance
Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA
First and foremost, maintaining adequate hydration is essential
Move Daily: Start with 10 minutes of exercise per day, building up to 150 minutes per week
Novo Nordisk published a cross-trial comparison claiming its Wegovy pill produced greater weight loss than Eli Lilly $LLY's newly approved obesity tablet Foundayo, raising the stakes as the two companies compete to shape prescribing trends in the oral GLP-1 market.
US$ 24.20
US$ 24.93
US$ 20.40
US$ 23.91
US$ 21.62
US$ 27.05
US$ 21.41
US$ 23.69
